UK & USA NEWS

Sarepta stock falls on FDA gene therapy Elevidys comment

Sagar2 weeks ago08 mins

Douglas Ingram, president and chief executive officer of Sarepta Therapeutics Inc., during the Forbes Healthcare Summit in New York, US, on Tuesday, Dec. 5, 2023. Michael Nagle | Bloomberg | Getty Images Shares of Sarepta Therapeutics plunged more than 30% on Friday as the future of its approved gene therapy treatment appeared at risk. The…

FDA to consider drug affordability when speeding up approvals: Makary

Sagar3 weeks ago06 mins

The Food and Drug Administration will consider drug affordability when granting companies new vouchers that speed up approvals of some treatments, the agency’s Commissioner Marty Makary told CNBC on Friday. The FDA in June announced a national priority voucher plan that aims to cut drug review times to one-to-two months for companies it says are…

After TikTok, Chinese businesses like Kling ramp up AI for video

Padres acquire Ryan O’Hearn, Ramon Laureano from Orioles

Ford posts first quarterly loss in two years after $800 million tariff hit

How Asian countries are reacting to Trump’s latest tariff announcements as deadline looms

Charlie Woods T-2 at Junior PGA, looks to seal Ryder Cup spot

Trump doubles down on call for Senate nominees before breaking for August recess

Marty Makary

Sarepta stock falls on FDA gene therapy Elevidys comment